GLP-1 medications, initially developed for diabetes and weight loss, are now being investigated for a wider range of potential health benefits, including cancer prevention and addiction treatment. Recent attention has focused on the expanding possibilities of these drugs, generating significant public interest. However, experts caution that while early research is promising, the full extent of these benefits remains unclear and requires further scientific investigation. The current understanding of GLP-1s’ effects beyond metabolic regulation is still evolving. Researchers emphasize the need for comprehensive studies to confirm these potential advantages and understand long-term impacts. Despite the excitement, a cautious approach to interpreting current findings is warranted, as science continues to explore the full therapeutic potential of GLP-1 drugs.